- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/24 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 239/24
Total number of patents in this class: 144
10-year publication summary
|
14
|
5
|
15
|
9
|
9
|
13
|
4
|
4
|
9
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17682 |
7 |
| Arvinas Operations, Inc. | 242 |
7 |
| Samsung Display Co., Ltd. | 35888 |
4 |
| Beyondbio Inc. | 9 |
4 |
| Boehringer Ingelheim International GmbH | 4648 |
3 |
| Calitor Sciences, LLC | 37 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2615 |
3 |
| Hutchison MediPharma Limited | 104 |
3 |
| Medshine Discovery Inc. | 598 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
3 |
| Merck Sharp & Dohme LLC | 3734 |
3 |
| Merck Sharp & Dohme Corp. | 2190 |
2 |
| AstraZeneca AB | 2857 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11527 |
2 |
| University of Florida Research Foundation, Inc. | 4074 |
2 |
| 10X Genomics, Inc. | 1266 |
2 |
| Advenchen Pharmaceuticals, LLC | 22 |
2 |
| Curtana Pharmaceuticals, Inc. | 13 |
2 |
| Gracel Display Inc. | 21 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 182 |
2 |
| Other owners | 83 |